Back to Search Start Over

Hepatic Macrophage as a Key Player in Fatty Liver Disease.

Authors :
Xu, Liyun
Liu, Wen
Bai, Fuxiang
Xu, Yong
Liang, Xiaohong
Ma, Chunhong
Gao, Lifen
Source :
Frontiers in Immunology; 12/9/2021, Vol. 12, p1-16, 16p
Publication Year :
2021

Abstract

Fatty liver disease, characterized by excessive inflammation and lipid deposition, is becoming one of the most prevalent liver metabolic diseases worldwide owing to the increasing global incidence of obesity. However, the underlying mechanisms of fatty liver disease are poorly understood. Accumulating evidence suggests that hepatic macrophages, specifically Kupffer cells (KCs), act as key players in the progression of fatty liver disease. Thus, it is essential to examine the current evidence of the roles of hepatic macrophages (both KCs and monocyte-derived macrophages). In this review, we primarily address the heterogeneities and multiple patterns of hepatic macrophages participating in the pathogenesis of fatty liver disease, including Toll-like receptors (TLRs), NLRP3 inflammasome, lipotoxicity, glucotoxicity, metabolic reprogramming, interaction with surrounding cells in the liver, and iron poisoning. A better understanding of the diverse roles of hepatic macrophages in the development of fatty liver disease may provide a more specific and promising macrophage-targeting therapeutic strategy for inflammatory liver diseases. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16643224
Volume :
12
Database :
Complementary Index
Journal :
Frontiers in Immunology
Publication Type :
Academic Journal
Accession number :
154043988
Full Text :
https://doi.org/10.3389/fimmu.2021.708978